Investor Information D R J E R E M Y L E V I N E X E C U T I V E C H A I R A N D C E O November 2026 Important notice and disclaimer This presentation has been prepared by Ceryvyn Therapeutics Limited (ABN 32 006 340 567) (“ Cer yvyn” or “Company”) to provide summary information about Cer...
Investor Presentation
Filed with ASX · · 24 pages · English
Release
Ceryvyn Therapeutics Limited on 6ix
In the deck
Earlier from Ceryvyn Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Change of Auditor
- Notice of Annual General Meeting/Proxy Form
- Change in substantial holding
- Notification regarding unquoted securities - CYV
Later from Ceryvyn Therapeutics
All Ceryvyn Therapeutics news releasesFollow Ceryvyn Therapeutics into a list and get an email when it puts out news.
Follow Ceryvyn Therapeutics